Status:
COMPLETED
Innovative Treatments for Neurogenic Dysphagia
Lead Sponsor:
IRCCS National Neurological Institute "C. Mondino" Foundation
Collaborating Sponsors:
ASST Santi Paolo e Carlo
L. Sacco Department of Biomedical and Clinical Sciences, Milano, Italy
Conditions:
Stroke, Complication
Parkinson's Disease
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study aims to evaluate different non-invasive and neuromuscular stimulation treatments for neurogenic dysphagia in post-stroke and Parkinson's disease patients. The study is divided into three su...
Detailed Description
Neurogenic dysphagia, commonly seen in post-stroke and Parkinson's disease patients, significantly impacts quality of life. Despite emerging treatments, there remains a lack of consensus on the best a...
Eligibility Criteria
Inclusion
- Adults aged 18-85 years
- Diagnosis of post-stroke or Parkinson's disease-related dysphagia
- Dysphagia duration ≥ 2 weeks for post-stroke patients and ≥ 6 months for Parkinson's disease patients
- Ability to undergo rehabilitation therapy
- Written informed consent obtained
Exclusion
- Severe dysphagia requiring Percutaneous Endoscopic Gastrostomy (PEG) feeding for more than 1 year
- Non-neurogenic causes of dysphagia
- Contraindications to tDCS or NMES
- Cognitive impairment affecting compliance with treatment
Key Trial Info
Start Date :
June 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT07152899
Start Date
June 15 2021
End Date
May 15 2025
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Translational Neurophysiology
Pavia, Italy, 27100